Craig E Masse

This inventor holds 72 USPTO granted patents and 31 published patent applications, plus 4 CIPO patents and 20 EPO patents, primarily in JAK2 Inhibitors (CPC class C07D). Top assignees: Nimbus Lakshmi, Inc., Concert Pharmaceuticals, Inc., Amgen Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig E Masse. Retrieved from https://idiyas.com/inventor/craig-e-masse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 72 (Patent Applications = 31)

% Patents Active = 79.2

CIPO Patents = 4 (Patent Applications = 15)

EPO Patents = 20 (Patent Applications = 40)

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 395(Granted Patents)

Forward Citations (Not Self Cited) = 244(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Concert Pharmaceuticals, Inc.

Nimbus Lakshimi, Inc.

patents

7. 5 out of 5

Ajax Therapeutics, Inc.

patents

8. 3 out of 1,228

Takeda Pharmaceutical Company Limited

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

JAK2 Inhibitors

TYK2 Inhibitors

ACC Inhibitors

IRAK Inhibitors

Bicyclic Compounds

Pyrazolo Compounds

Heteroaryl Compounds

Amino Compounds

Compositions

Uses

Substituted Compounds

Methods for Production

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338242 - TYK2 inhibitors and uses thereof (2025-06-24),

2. 12275717 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2025-04-14),

3. 12221453 - Substituted pyrazolo[5',1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 inhibitors (2025-02-11),

4. 12162881 - Forms and compositions of inhibitors of JAK2 (2024-12-10),

5. 12043632 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2024-07-23),

6. 11970494 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2024-04-30),

7. 11834449 - TYK2 inhibitors and uses thereof (2023-12-05),

8. 11691963 - 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors (2023-07-04),

9. 11434240 - TYK2 inhibitors and uses thereof (2022-09-06),

10. 11414431 - Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitors (2022-08-16),

11. 11396508 - TYK2 inhibitors and uses thereof (2022-07-26),

12. 11220508 - TYK2 inhibitors and uses thereof (2022-01-11),

13. 11174264 - TYK2 inhibitors and uses thereof (2021-11-16),

14. 11053241 - TYK2 inhibitors and uses thereof (2021-07-06),

15. 11046698 - TYK2 inhibitors and uses thereof (2021-06-29),

Title: The Innovative Journey of Craig E Masse

Introduction: Craig E Masse is a pioneering inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Craig E Masse holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Craig E Masse has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have made a significant impact on society.

Collaborations: Throughout his career, Craig E Masse has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Craig E Masse's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the field.

Profile summary based on public USPTO records.